{"transactions":[{"id":811520,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-09T20:26:52.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":7061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted pursuant to the Plan. The shares underlying the options will vest on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":7061,"derivative":{"exercise_price":24.61,"expiration_date":"2036-04-07","underlying":"Common Stock","underlying_shares":7061},"source":{"system":"sec-edgar","filing":"0001764013-26-000048","document":"wk-form4_1775766410.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000048/wk-form4_1775766410.xml","form_type":"4"}},{"id":811519,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-09T20:26:52.000Z","date":"2026-04-07","kind":"grant","planned":false,"acquired":true,"shares":13880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") were granted pursuant to the Issuer's 2019 Equity Incentive Plan (the \"Plan\"). Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 1, 2027, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A."}],"balance_after":134653,"source":{"system":"sec-edgar","filing":"0001764013-26-000048","document":"wk-form4_1775766410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401326000048/wk-form4_1775766410.xml","form_type":"4"}},{"id":981643,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T23:14:22.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":1909,"price":23.96,"value":45739.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares of common stock reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2025 in order to satisfy applicable tax obligations arising in connection with the vesting and deferred settlement of a prior award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.75 - $24.13 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":120773,"source":{"system":"sec-edgar","filing":"0001764013-25-000159","document":"wk-form4_1764803660.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000159/wk-form4_1764803660.xml","form_type":"4"}},{"id":981642,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T23:14:22.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":13091,"price":23.14,"value":302925.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares of common stock reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2025 in order to satisfy applicable tax obligations arising in connection with the vesting and deferred settlement of a prior award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.75 - $23.73 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":122682,"source":{"system":"sec-edgar","filing":"0001764013-25-000159","document":"wk-form4_1764803660.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000159/wk-form4_1764803660.xml","form_type":"4"}},{"id":1179753,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-03T20:43:04.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":7600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the options will vest on April 1, 2026, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":7600,"derivative":{"exercise_price":15.2,"expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":7600},"source":{"system":"sec-edgar","filing":"0001764013-25-000045","document":"wk-form4_1743712974.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000045/wk-form4_1743712974.xml","form_type":"4"}},{"id":1179752,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-03T20:43:04.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":16188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 1, 2026, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A."}],"balance_after":135773,"source":{"system":"sec-edgar","filing":"0001764013-25-000045","document":"wk-form4_1743712974.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401325000045/wk-form4_1743712974.xml","form_type":"4"}},{"id":1343073,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-04T21:20:16.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":5425,"price":28.54,"value":154829.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares of common stock reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted  by the Reporting Person on June 16, 2023 in order to satisfy applicable tax obligations arising in connection with the vesting and deferred settlement of a prior award of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.05 - $28.99 per share, inclusive. The Reporting Person undertakes to provide\nto the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote to this Form 4."}],"balance_after":119585,"source":{"system":"sec-edgar","filing":"0001764013-24-000199","document":"wk-form4_1733347209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000199/wk-form4_1733347209.xml","form_type":"4"}},{"id":1547843,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-04T20:50:16.000Z","date":"2024-04-02","kind":"grant","planned":false,"acquired":true,"shares":4690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the options will vest on April 2, 2025, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":4690,"derivative":{"exercise_price":30.78,"expiration_date":"2034-04-02","underlying":"Common Stock","underlying_shares":4690},"source":{"system":"sec-edgar","filing":"0001764013-24-000065","document":"wk-form4_1712263802.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000065/wk-form4_1712263802.xml","form_type":"4"}},{"id":1547842,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-04T20:50:16.000Z","date":"2024-04-02","kind":"grant","planned":false,"acquired":true,"shares":11255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest in full on April 2, 2025, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A."}],"balance_after":125010,"source":{"system":"sec-edgar","filing":"0001764013-24-000065","document":"wk-form4_1712263802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000065/wk-form4_1712263802.xml","form_type":"4"}},{"id":1919637,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-14T20:35:30.000Z","date":"2023-04-12","kind":"grant","planned":false,"acquired":true,"shares":16260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the options vest one year after the date of grant on April 12, 2024, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":16260,"derivative":{"exercise_price":14.7,"expiration_date":"2033-04-12","underlying":"Common Stock","underlying_shares":16260},"source":{"system":"sec-edgar","filing":"0001764013-23-000046","document":"wf-form4_168150451547406.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401323000046/wf-form4_168150451547406.xml","form_type":"4"}},{"id":1919636,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-14T20:35:30.000Z","date":"2023-04-12","kind":"grant","planned":false,"acquired":true,"shares":12523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the number of shares underlying restricted stock units awards (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest in their entirety one year after the date of grant on April 12, 2024, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A."}],"balance_after":113755,"source":{"system":"sec-edgar","filing":"0001764013-23-000046","document":"wf-form4_168150451547406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401323000046/wf-form4_168150451547406.xml","form_type":"4"}},{"id":2104015,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Subscription Rights (right to buy)","published_at":"2022-11-25T18:05:22.000Z","date":"2022-11-23","kind":"other","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents exercise price per whole share of Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Rights Offering expired on November 17, 2022, and final determination of the pro rata allocation for each exercising holder was determined on November 22, 2022."}],"balance_after":0,"derivative":{"exercise_price":0.5,"exercise_date":"2022-10-31","underlying":"Common Stock","underlying_shares":71363},"source":{"system":"sec-edgar","filing":"0000899243-22-037001","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710863/000089924322037001/doc4.xml","form_type":"4"}},{"id":2104014,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-25T18:05:22.000Z","date":"2022-11-22","kind":"other","acquired":true,"shares":71363,"price":0.5,"value":35681.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's Common Stock acquired by the Reporting Person following the exercise of his basic subscription rights in connection with the Issuer's rights offering to holders of Common Stock, as described in the issuer's prospectus dated October 27, 2022 (the \"Rights Offering\"). Each holder of Common Stock of record as of October 24, 2022 received one right for each share of Common Stock, and each right entitled the holder of Common Stock to purchase 9.5151 shares of Common Stock at the subscription price of $0.50 per whole share."}],"balance_after":107072,"source":{"system":"sec-edgar","filing":"0000899243-22-037001","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710863/000089924322037001/doc4.xml","form_type":"4"}},{"id":2136849,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-14T20:05:10.000Z","date":"2022-10-12","kind":"grant","acquired":true,"shares":74074,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option vests and becomes exercisable as to 1/12th of the underlying shares on each monthly anniversary of the date of the grant, provided, that if the Company's annual meeting immediately following the date of grant takes place prior to the first anniversary of the date of grant, the Stock Option will vest and become exercisable immediately prior to the Company's annual meeting following the date of grant, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":74074,"derivative":{"exercise_price":0.7,"expiration_date":"2032-10-11","underlying":"Common Stock","underlying_shares":74074},"source":{"system":"sec-edgar","filing":"0000899243-22-033643","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710863/000089924322033643/doc4.xml","form_type":"4"}},{"id":2173643,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-08-25T23:36:18.000Z","date":"2022-08-23","kind":"grant","acquired":true,"shares":74805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option vests and becomes exercisable as to 1/12th of the underlying shares on each monthly anniversary of November 9, 2021, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":74805,"derivative":{"exercise_price":2.48,"expiration_date":"2032-08-22","underlying":"Common Stock","underlying_shares":74805},"source":{"system":"sec-edgar","filing":"0000899243-22-029777","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710863/000089924322029777/doc4.xml","form_type":"4"}},{"id":2178365,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-08-19T20:41:28.000Z","date":"2022-08-17","kind":"grant","acquired":true,"shares":31668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the options vest one year after the date of grant on August 17, 2023, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":31668,"derivative":{"exercise_price":4.99,"expiration_date":"2032-08-17","underlying":"Common Stock","underlying_shares":31668},"source":{"system":"sec-edgar","filing":"0001764013-22-000091","document":"wf-form4_166094167115623.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401322000091/wf-form4_166094167115623.xml","form_type":"4"}},{"id":2178364,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-19T20:41:28.000Z","date":"2022-08-17","kind":"grant","acquired":true,"shares":21059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the number of shares underlying restricted stock units awards (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest in their entirety one year after the date of grant on August 17, 2023, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A."}],"balance_after":101232,"source":{"system":"sec-edgar","filing":"0001764013-22-000091","document":"wf-form4_166094167115623.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401322000091/wf-form4_166094167115623.xml","form_type":"4"}},{"id":2436891,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-12T22:00:26.000Z","date":"2022-01-10","kind":"grant","acquired":true,"shares":71492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date."}],"balance_after":208973,"derivative":{"exercise_price":7.94,"expiration_date":"2032-01-10","underlying":"Common Stock","underlying_shares":71492},"source":{"system":"sec-edgar","filing":"0001764013-22-000017","document":"wf-form4_164202480829515.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401322000017/wf-form4_164202480829515.xml","form_type":"4"}},{"id":2436890,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-12T22:00:26.000Z","date":"2022-01-10","kind":"grant","acquired":true,"shares":21726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the number of shares underlying restricted stock units awards (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date."}],"balance_after":80173,"source":{"system":"sec-edgar","filing":"0001764013-22-000017","document":"wf-form4_164202480829515.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401322000017/wf-form4_164202480829515.xml","form_type":"4"}},{"id":2586663,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-30T13:08:53.000Z","date":"2021-08-27","kind":"purchase","acquired":true,"shares":18247,"price":8.24,"value":150355.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.22 - $8.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":58447,"source":{"system":"sec-edgar","filing":"0001764013-21-000092","document":"wf-form4_163032892005129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401321000092/wf-form4_163032892005129.xml","form_type":"4"}},{"id":2736869,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-28T21:14:08.000Z","date":"2021-04-27","kind":"sale","acquired":false,"shares":1500,"price":55,"value":82500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares."}],"balance_after":35709,"source":{"system":"sec-edgar","filing":"0000899243-21-017193","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710863/000089924321017193/doc4.xml","form_type":"4"}},{"id":2775014,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-23T12:52:23.000Z","date":"2021-03-19","kind":"grant","acquired":true,"shares":23300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the options vest one year after the date of grant on March 19, 2022, subject to the Reporting Person's continuous service to the Issuer as of such date."}],"balance_after":23300,"derivative":{"exercise_price":17,"expiration_date":"2031-03-19","underlying":"Common Stock","underlying_shares":23300},"source":{"system":"sec-edgar","filing":"0001764013-21-000042","document":"wf-form4_161650393243276.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401321000042/wf-form4_161650393243276.xml","form_type":"4"}},{"id":2775013,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-23T12:52:23.000Z","date":"2021-03-19","kind":"grant","acquired":true,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying restricted stock unit awards (\"RSUs\") granted to the Reporting Person pursuant to a non-employee director grant. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest in their entirety one year after the date of grant on March 19, 2022, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A."}],"balance_after":40200,"source":{"system":"sec-edgar","filing":"0001764013-21-000042","document":"wf-form4_161650393243276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000176401321000042/wf-form4_161650393243276.xml","form_type":"4"}},{"id":3001234,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2020-10-22T23:29:17.000Z","date":"2020-10-20","kind":"exercise","acquired":false,"shares":33259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series C Preferred Stock automatically converted into shares of Common Stock on a 1:1.118772093 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series C Preferred Stock automatically converted into shares of Common Stock on a 1:1.118772093 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series C Preferred Stock automatically converted into shares of Common Stock on a 1:1.118772093 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":37209},"source":{"system":"sec-edgar","filing":"0000899243-20-029075","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710863/000089924320029075/doc4.xml","form_type":"4"}},{"id":3001233,"issuer":{"id":94112,"kind":"organization","name":"Eargo, Inc.","symbol":"EAR"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-22T23:29:17.000Z","date":"2020-10-20","kind":"exercise","acquired":true,"shares":37209,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series C Preferred Stock automatically converted into shares of Common Stock on a 1:1.118772093 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."}],"balance_after":37209,"source":{"system":"sec-edgar","filing":"0000899243-20-029075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710863/000089924320029075/doc4.xml","form_type":"4"}},{"id":3145701,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-18T12:42:13.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest in eight equal quarterly installments measured from May 15, 2020, subject to the Reporting Person providing continuous service to the Issuer as of each such date."}],"balance_after":37000,"derivative":{"exercise_price":19.01,"expiration_date":"2030-05-14","underlying":"Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0001209191-20-029936","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000120919120029936/doc4.xml","form_type":"4"}},{"id":3145700,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-18T12:42:13.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":24700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares underlying restricted stock units awards (\"RSUs\") pursuant to a non-employee director grant. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest in two equal annual installments on May 15, 2021 and May 15, 2022, subject to the Reporting Person's continued service to the Issuer as of each such date; provided that each director may elect to defer settlement of the RSUs upon vesting, subject to Rule 409A regulation."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares underlying restricted stock units awards (\"RSUs\") pursuant to a non-employee director grant. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest in two equal annual installments on May 15, 2021 and May 15, 2022, subject to the Reporting Person's continued service to the Issuer as of each such date; provided that each director may elect to defer settlement of the RSUs upon vesting, subject to Rule 409A regulation."}],"balance_after":24700,"source":{"system":"sec-edgar","filing":"0001209191-20-029936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000120919120029936/doc4.xml","form_type":"4"}},{"id":3334026,"issuer":{"id":3632,"kind":"organization","name":"Immunovant, Inc.","symbol":"IMVT"},"owners":[{"id":53086,"kind":"person","name":"Hughes Douglas J.","position":1,"cik":"0001710863","reported_name":"Hughes Douglas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-20T21:53:28.000Z","date":"2019-12-18","kind":"grant","acquired":true,"shares":77181,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the share exchange transaction pursuant to which Health Sciences Acquisitions Corporation (\"HSAC\") acquired 100% of the issued and outstanding shares of Immunovant Sciences Ltd., the option to purchase 157,812 shares of Immunovant Sciences Ltd. at exercise price of $4.12 per share, was assumed by HSAC and converted into an option to purchase shares of the Issuer (formerly known as HSAC)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests over a period of three years, with 1/3 of the shares underlying the option vesting on each of the first, second and third anniversaries of the vesting commencement date."}],"balance_after":77181,"derivative":{"exercise_price":8.43,"expiration_date":"2029-11-19","underlying":"Common Stock","underlying_shares":77181},"source":{"system":"sec-edgar","filing":"0001209191-19-061590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1764013/000120919119061590/doc4.xml","form_type":"4"}}]}